Valuation Realcan Pharmaceutical Group Co., Ltd.

Stocks

End-of-day quote Shenzhen S.E. 27/10/2026			5-day change	1st Jan Change
2.790 ^CNY	-4.12%		-5.74%	-13.35%

10-26	Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2026	CI
09-21	Realcan Pharmaceutical Group Co., Ltd.(XSEC:002589) added to S&P Global BMI Index	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	7,826	5,881	6,165	4,920	4,444	4,779
Change	-	-24.86%	4.83%	-20.19%	-9.67%	7.54%
Enterprise Value (EV) ¹	12,117	5,846	4,743	6,684	6,040	5,640
Change	-	-51.75%	-18.87%	40.92%	-9.64%	-6.63%
P/E	24.9x	43.7x	-3.32x	242x	217x	322x
PBR	1.05x	0.78x	1.14x	0.9x	0.81x	0.89x
PEG	-	-0.8x	0x	-2x	146.48x	-11.9x
Capitalization / Revenue	0.29x	0.28x	0.5x	0.61x	0.56x	0.66x
EV / Revenue	0.45x	0.28x	0.39x	0.83x	0.76x	0.77x
EV / EBITDA	7.21x	5.33x	36.2x	70x	31.4x	25.5x
EV / EBIT	8.64x	7.19x	-43.6x	-79.3x	196x	78x
EV / FCF	-4.62x	1.03x	0.99x	-1.81x	-56.6x	5.15x
FCF Yield	-21.7%	97.1%	101%	-55.3%	-1.77%	19.4%
Dividend per Share ²	0.018	0.009	-	0.013	0.011	0.002
Rate of return	0.34%	0.23%	-	0.4%	0.37%	0.06%
EPS ²	0.21	0.09	-1.242	0.0135	0.0137	0.01
Distribution rate	8.57%	10%	-	96.3%	80.3%	20%
Net sales ¹	27,204	21,060	12,311	8,034	7,966	7,296
EBITDA ¹	1,680	1,097	131.2	95.5	192.3	221.5
EBIT ¹	1,402	813.4	-108.7	-84.27	30.76	72.26
Net income ¹	261.3	131.2	-1,832	20.32	20.62	16.07
Net Debt ¹	4,290	-34.82	-1,422	1,764	1,595	860.3
Reference price ²	5.230	3.930	4.120	3.270	2.970	3.220
Nbr of stocks (in thousands)	1,496,437	1,496,437	1,496,437	1,504,710	1,496,437	1,484,264
Announcement Date	3/30/21 A	4/29/22 A	4/28/23 A	4/29/24 A	4/23/25 A	4/22/26 A

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
REALCAN PHARMACEUTICAL GROUP CO., LTD.	-	-	-	-	615M
ELI LILLY AND COMPANY	37.66x	13.18x	27.98x	0.53%	1,143B
JOHNSON & JOHNSON	39.33x	6.61x	18.6x	1.99%	647B
ABBVIE INC.	37.45x	8.4x	17.37x	2.4%	506B
ROCHE HOLDING AG	21.46x	5.22x	12.98x	2.51%	384B
MERCK & CO., INC.	103.38x	5.8x	24.86x	2.4%	350B
NOVARTIS AG	21.99x	5.69x	13.69x	2.94%	293B
ASTRAZENECA PLC	22.31x	4.51x	12.87x	1.96%	265B
AMGEN INC.	28.42x	7.28x	13.03x	2.25%	242B
GILEAD SCIENCES, INC.	-45.78x	7.1x	27.53x	2.07%	197B
Average	29.58x	7.09x	18.77x	2.12%	402.81B
Weighted average by Cap.	35.27x	8.35x	20.48x	1.8%